Background {#Sec1}
==========

A tandem repeat is a region where multiple adjacent copies of sequence reside in the genomic DNA. These regions are highly variable among individuals due to replication error during cell division. They are a source of phenotypic variability in disease and health. More than 30 human diseases are caused by copy number alterations in tandem repeats \[[@CR1]\].

The range of pathogenic copy number change relative to the reference varies from a few copies to several thousand, and the length of repeating unit varies from, e.g., three (triplet repeat disease) to several thousand (macro-satellite repeat). As might be expected from such diverse underlying genetic causes, disease mechanisms are also variable. Well-known examples of triplet-repeat expansion diseases in protein-coding regions are polyglutamine diseases (e.g., spinal and bulbar muscular atrophy, Huntington's disease) \[[@CR2], [@CR3]\]. Triplet repeat expansion of CAG or CAA codons, which encode glutamine, leads to toxic protein aggregation and neuronal cell death. Another example of triplet-repeat disease is caused by CUG repeat expansion in the 3'UTR of the transcript from the *DMPK* gene, producing a toxic gain-of-function transcript which sequesters splicing factor proteins and causes aberrant splicing, resulting in multiple symptoms \[[@CR4]\]. Not only gain-of-function mutations, but also loss-of-function repeat change in the promoter region due to transcriptional silencing has been reported (e.g., fragile X syndrome) \[[@CR5]\]. In addition to short tandem repeat diseases, repeat copy number aberration in human disease is also reported in a macro-satellite repeat (D4Z4). Shortening of the D4Z4 repeat causes aberrant expression of the flanking gene *DUX4*, which has a toxic effect in muscle cells \[[@CR6]\]. The thresholds of pathogenic repeat expansion in coding regions are usually less than 100 copies and sometimes even a few copy differences can cause disease (e.g., oculopharyngeal muscular dystrophy) \[[@CR7]\]. In contrast, some disease-causing tandem repeat expansions in introns or UTRs can be very long (e.g., *DMPK*) \[[@CR4]\]. Moreover, some repeats are interrupted by different sequences (e.g., *DMPK*, *ATXN10*, *SAMD12*) \[[@CR8]--[@CR10]\], making it difficult to analyze the precise repeat structure.

It has been roughly a decade since the introduction of high throughput short read sequencers to clinical genetics. There have been numerous successful identifications of small nucleotide changes, especially in coding regions, mainly thanks to targeted sequencing (e.g., whole exome sequencing). However, the diagnostic rate remains 30% (depending on the diagnostic platform used) \[[@CR11]\], leaving a large population of Mendelian diseases unsolved. The remaining patients may have mutations in "non-coding regions," or mutations in coding regions which were overlooked due to the limitations of short read sequencing \[[@CR12]\]. One candidate is tandem repeat regions, which are difficult to analyze genome-wide by conventional techniques. Identification of disease-causing tandem repeat changes is usually realized by classical genetic technologies (i.e., linkage analysis, Southern blot) and targeted repeat region analysis in a large number of families.

The recent advancement of long-read sequencing technologies may provide a good solution, because long enough reads can encompass whole expanded repeats, and can be analyzed using the flanking unique sequences. Long-read sequencers (PacBio and nanopore) have begun to appear in clinical genetics very recently \[[@CR13]\]. As of 2018, these technologies are continually improving in accuracy and throughput. In the clinical laboratory, however, these technologies are still problematic due to both sequencing cost efficiency and the computing burden for large data. It would be preferable, and practical, if low coverage data (\~ 10×) can be used to detect alteration of tandem repeats.

We are aware of two previous methods for determining tandem repeat copy number from long DNA reads: PacmonSTR and RepeatHMM \[[@CR14], [@CR15]\]. These methods align the reads to a reference genome, then get the reads that cover a tandem repeat region of the reference, and perform sophisticated probability-based comparisons of these reads to the sequence of the repeating unit. In this study, however, we find that these methods do not always succeed with current long-read data.

We have recently advocated a method (using LAST software) for aligning DNA reads to a genome allowing for rearrangements and duplications \[[@CR16]\]. This method has two key features. First: it determines the rates of insertion, deletion, and each kind of substitution in the data and uses these rates to determine the most probable alignments \[[@CR17]\]. Second: it finds the most probable division of each read into (one or more) parts together with the most probable alignment of each part. This method found diverse types of rearrangement, the most common of which was tandem multiplication (e.g., heptuplication), often of tandem repeat regions \[[@CR16]\].

Here, we detect tandem repeat copy number changes by aligning long DNA reads to a reference genome with LAST, and analyzing these alignments in a crude-but-effective way (Fig. [1](#Fig1){ref-type="fig"}). Our analysis is based on LAST's division of reads into non-overlapping parts, with a mismap probability (i.e., alignment ambiguity) for each part, and its treatment of "simple" sequence (see the "[Methods](#Sec15){ref-type="sec"}" section). We point out several practical difficulties with analyzing tandem repeat sequences, which motivate our crude analysis method. Our approach is capable of analyzing tandem repeats genome-wide even with relatively low coverage sequencing data. We believe that this tool will be useful for identifying disease-causing mutations in tandem repeat regions which have been overlooked by short read sequencing in human disease.Fig. 1Flow chart to predict and prioritize tandem repeat changes, using the tandem-genotypes and tandem-genotypes-join programs. Long reads are aligned to a reference genome using LAST. Dotted square: program developed in this study

Results {#Sec2}
=======

Nanopore sequencing of tandem repeat containing plasmids {#Sec3}
--------------------------------------------------------

To test our method, we analyzed artificial DNA plasmids containing four different kinds of tandem repeat (CAG, CAA, GGGGCC, and iCCTG) that are known to cause human diseases. We used plasmids with various copy numbers of the repeat unit (e.g., 15 and 109 for CAA; see Fig. [2](#Fig2){ref-type="fig"}). These plasmids were subjected to Oxford Nanopore Technologies' (ONT) MinION sequencing. The MinION reads were aligned to plasmid reference sequences with copy number 6 (CAG), 15 (CAA), 3 (GGGGCC), and 15 (CCTG). tandem-genotypes predicted the copy number change in each read (Fig. [1](#Fig1){ref-type="fig"}): these predictions roughly agree with the actual copy number changes (Fig. [2](#Fig2){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S1). There is a minority of unexpectedly low copy number predictions (Fig. [2](#Fig2){ref-type="fig"}d, i; black arrow), especially for the longer plasmids: manual inspection of alignment dotplots (not shown) suggests that these are correct, and the copy numbers in these plasmids may not be completely stable.Fig. 2**a**--**j** Distribution of predicted change in repeat copy number, for nanopore reads from each of ten plasmids. Red arrows: expected copy number change. Forward (red) and reverse strand reads (blue) are shown separately. *y*-axis: read count, *x*-axis: change in copy number relative to the reference plasmid. Reference copy numbers in each plasmid are in Additional file [1](#MOESM1){ref-type="media"}: Table S7. Black arrows: reads in these peaks may actually have shortened repeats

In one case, pBS-(CAG)30, tandem-genotypes failed with almost no predictions. pBS-(CAG)30 was linearized by cutting it very near to the repeat region (10-bp upstream, see the "[Methods](#Sec15){ref-type="sec"}" section), so there is only 10 bp of non-repeat sequence upstream of the repeat, which is too short for step 2 of tandem genotypes (see the "[Methods](#Sec15){ref-type="sec"}" section). Thus, we cut the same plasmid with a different enzyme, DraIII, far from the repeat. As expected, the tandem-genotypes prediction agrees with the actual copy number change (Additional file [1](#MOESM1){ref-type="media"}: Figure S2a, red arrow).

The GGGGCC repeats have bimodal copy number predictions, where the two modes correspond to reads from each DNA strand (Fig. [2](#Fig2){ref-type="fig"}h, i, Additional file [1](#MOESM1){ref-type="media"}: Figure S2b). A plausible explanation of this would be if sequencing errors are not independent of the sequence. For example, deletion errors might be more common in GGCCCC repeats than in GGGGCC repeats.

Analyzing chimeric human/plasmid nanopore reads {#Sec4}
-----------------------------------------------

We performed further tests on semi-artificial data. We obtained human nanopore reads (from "rel3" \[[@CR18]\]) that cover 10 disease-associated repeat regions and replaced the repeat region in each read with the repeat region of a plasmid nanopore read. We used plasmid repeat regions with disease-causing and healthy repeat copy numbers in 1:1 ratio (Table [1](#Tab1){ref-type="table"}). These chimeric reads were aligned to a reference human genome, and copy-number changes were predicted. For each repeat, the predictions have clear bimodal distributions close to the expected copy numbers (Fig. [3](#Fig3){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: see the "[Results](#Sec2){ref-type="sec"}" section, Figure S3).Table 1Chimera readschrStartEndRepeatGeneRegionRepeat number in referenceInserted repeat 1Inserted repeat 2Expected change 1Expected change 2Read number 1Read number 2Tandem-genotypes detectedTotal mapped readschr363,912,68663,912,715CAG*ATXN7*Coding10630− 42024242830chr3129,172,577129,172,656CCTG*CNBP*Intron21Raw data45NA2418173133chr43,074,8773,074,933CAG*HTT*Coding21670− 154921203138chr5146,878,729146,878,758CAG*PPP2R2B*Intron10670− 46011102121chr927,573,52927,573,546GGGGCC*C9orf72*Intron32152184914142326chr126,936,7296,936,773CAG*ATN1*Coding15187035518203638chr12111,598,951111,599,019CAG*ATXN2*Coding23307074720203436chr1492,071,01192,071,034CAG*ATXN3*Coding106130− 412015153030chr1913,207,85913,207,897CAG*CACNA1A*Coding13630− 71718173134chrX67,545,31867,545,383CAG*AR*Coding231870− 54721201822Fig. 3**a**--**j** Distribution of predicted change in repeat copy number, for nanopore reads of human DNA with inserted repeats. Reads covering each of ten disease-associated repeat loci were selected, and the repeat region in each read was replaced by the repeat region of a plasmid nanopore read. *y*-axis: read count, *x*-axis: change in copy number relative to the reference human genome. Forward (red) and reverse strand reads (blue) are shown separately. Red arrows: projected repeat copy changes

We also analyzed this semi-artificial data using RepeatHMM and PacmonSTR. RepeatHMM did not clearly detect any of the projected repeat expansions (Additional file [1](#MOESM1){ref-type="media"}: Figure S4). PacmonSTR produced no output.

PacBio sequencing datasets of patients with SCA10 {#Sec5}
-------------------------------------------------

Next, we examined four PacBio sequencing datasets of cloned PCR amplification products from the SCA10 disease locus (spinocerebellar ataxia 10, MIM 603516). SCA10 is caused by ATTCT expansion in the intron of *ATXN10*. These datasets are from three unrelated patients: A, B, and C \[[@CR9]\]. Patient C has two datasets, C-1 and C-2, which are different clones sequenced with different PacBio chemistries. According to McFarland et al., subjects A, B, and C have 4.5 kb, 3.9 kb, and 2.7 kb repeat expansions (since PCR product sizes are 6.5 kb, 5.9 kb, and 4.7 kb and they contain 2 kb flanking sequences), respectively \[[@CR9]\]. tandem-genotypes predicted datasets A, B, C-1, and C-2 have average expansions of 913, 841, 484, and 486 copies relative to the reference (14 copies), hence repeat lengths 4.6 kb, 4.3 kb, 2.5 kb, and 2.5 kb, respectively (Fig. [4](#Fig4){ref-type="fig"}a). Thus, subject B is predicted to have 0.4 kb larger repeat size than the PCR product; however, from McFarland et al. Fig. [1](#Fig1){ref-type="fig"}b \[[@CR9]\], the purified clone they sequenced by PacBio had \> 6 kb insertion, making the actual repeat size \> 4 kb, closer to our prediction.Fig. 4Distribution of predicted change in repeat copy number, for PacBio (RSII) reads of cloned SCA10 loci from 3 patients. **a** tandem-genotypes. Forward (red) and reverse strand reads (blue) are shown separately. **b** RepeatHMM with straightforward parameters. **c** RepeatHMM with non-obvious parameters suggested by its authors. *y*-axis: read count, *x*-axis: change in copy number relative to the reference human genome. Red arrow: expected repeat copy change, from McFarland et al. \[[@CR9]\]

The same datasets were also analyzed with RepeatHMM and PacmonSTR. We first ran RepeatHMM with straightforward parameters: for subject A, it found a similar peak to us but also an unexpected peak around zero, and it did not find the expected peaks for the other three datasets (Fig. [4](#Fig4){ref-type="fig"}b). We then consulted the RepeatHMM authors, who suggested non-obvious parameters that improved the C-2 result, but there was still a peak around zero (Fig. [4](#Fig4){ref-type="fig"}c). PacmonSTR did produce some output in this case, but none for the SCA10 locus.

Expanded inexact repeats in NA12878 {#Sec6}
-----------------------------------

Repeat annotations (i.e., RepeatMasker from UCSC) include non-exact tandem repeats. Non-exact or interrupted tandem repeats sometimes cause human disease \[[@CR8]\]. We detected inexact repeat expansions in the NA12878 human genome, by applying tandem-genotypes to PacBio and MinION datasets.

In an intron of *PCDH15*, RepeatMasker annotates a "TATAT" tandem repeat (chr10:54421448-54421530), though the actual sequence is not exactly TATAT (tatataaaat aaactttatt atatttagca tttgattttt atttatgtat attataaaat gaatatagtt tatattataa ta). tandem-genotypes found two peaks for this repeat, indicating a heterozygous \~ 300 bp insertion (Fig. [5](#Fig5){ref-type="fig"}a). PCR amplification of this region from NA12878 DNA showed two different products. One had the same length as the reference sequence (PCDH15-intron-repeat-S) (Fig. [5](#Fig5){ref-type="fig"}a). Sanger sequencing of the other longer PCR product (PCDH15-intron-repeat-L) revealed a \~ 332 bp insertion. Surprisingly, this insertion was not a tandem expansion, but rather an AluYb8 SINE (according to RepeatMasker).Fig. 5PCR results and Sanger sequencing of two tandem-repeat loci in human genome NA12878, with expansions relative to the reference human genome (hg38). Reads were aligned by MUSCLE \[[@CR33]\]. The histograms show read counts (*y*-axis) for predicted copy number changes (*x*-axis), with nanopore (rel3) in blue and PacBio (SRR3197748) in red. **a** Expansion of an inexact TATAT repeat in an intron of *PCDH15*: actually insertion of an AluYb8 SINE. **b** Expansion of an intergenic GT repeat: actually deletion in the reference human genome. The bands marked by asterisks were sequenced and proved to be non-target amplification

We also examined an intergenic GT tandem repeat (chr8:48173947-48174212). tandem-genotypes found one peak indicating an insertion of \~ 1000 bp (Fig. [5](#Fig5){ref-type="fig"}b). PCR of this region showed a single product, estimated to contain a \~ 1000 bp insertion. Sanger sequencing revealed that this expansion includes not only GT but also some unknown sequence. The expanded sequence is present in the chimpanzee genome (Fig. [5](#Fig5){ref-type="fig"}b), indicating that this is actually a deletion in the human reference genome (which may have occurred by recombination between GT tandem repeats).

These two examples indicate that tandem-genotypes can also find complex and interrupted expansions (or non-deletions) of tandem repeats. We also tested three structural variation (SV) finding methods: NGMLR-sniffles, nanoSV \[[@CR19], [@CR20]\], and PBSV (<https://github.com/PacificBiosciences/pbsv>). Only PBSV detected both expansions (Additional file [1](#MOESM1){ref-type="media"}: Table S1).

PacBio sequencing of a patient with BAFME {#Sec7}
-----------------------------------------

We further analyzed PacBio whole genome sequencing of a patient with a phenotype of benign adult familial myoclonic epilepsy (BAFME). In another large number of BAFME patients in Japan \[[@CR10]\], the cause was attributed to large expansions of intronic TTTCA and TTTTA repeats in *SAMD12*. We wished to know whether our patient has such an expansion in *SAMD12*. We sequenced this patient's genomic DNA using a PacBio Sequel sequencer. tandem-genotypes detected \~ 5 kb insertion in three reads at the BAFME locus, where the coverage is 6× (Fig. [6](#Fig6){ref-type="fig"}a). We also applied RepeatHMM, PacmonSTR, NGMLR-sniffles, PBSV, and nanoSV to this dataset, but they failed to predict any expansions in the BAFME locus (Additional file [1](#MOESM1){ref-type="media"}: Table S1). In this study, we used PBSV version 2.0.1 (see Additional file [1](#MOESM1){ref-type="media"}). In a parallel study conducted while this paper was in peer-review, surprisingly, an older version (PBSV v0.1.0) found this BAFME expansion as an "insertion" \[[@CR21]\]. These structural-variant-finding tools do not indicate which variants are repeat expansions, or of which repeats, and lack our critical prioritization/ranking functionality.Fig. 6Alignments of DNA reads (vertical) to the reference human genome (horizontal). Diagonal lines indicate alignments, of the same strands (red) and opposite strands (blue). The vertical stripes indicate repeat annotations in the reference genome: tandem repeats (purple) and transposable elements (pink). **a** Six reads from a BAFME patient that cover the disease-causing *SAMD12* AAAAT repeat locus. **b** Close-ups of three reads with \~ 5 k expansions. **c** Two examples of chimeric human reads (rel3) with expanded CAG repeats at the *ATXN7* disease locus

Some difficulties with tandem repeat analysis {#Sec8}
---------------------------------------------

The three expanded BAFME reads do not align with the repetitive region as would be expected for a straightforward repeat expansion (Fig. [6](#Fig6){ref-type="fig"}b). Read 2, from the forward genome strand, does not align to the repetitive region at all, because its expanded region consists mostly of TCCCC repeats whereas the forward strand of the reference genome has TAAAA repeats (Additional file [1](#MOESM1){ref-type="media"}: Figure S5). Reads 1 and 6, from the reverse genome strand, align to the repeat at only one side of the expansion. The expanded regions of these two reads start with TTTTA repeats, which match the reverse strand of the reference, but mostly consist of TTTTC repeats. Since the expanded region of read 2 does not match the reverse complement of read 1 or 6, we infer that systematic sequencing error has occurred on at least one strand. It is plausible that short-period tandem repeats suffer a nasty kind of sequencing error: if a systematic error occurs for one repeat unit, the same error will tend to occur for all the other units, producing a different repeat (which may align elsewhere in the genome: the main reason for step 2 in tandem-genotypes). Systematic TAAAA to TCCCC and TTTTA to TTTTC conversions occur in some other reads at other TTTTA repeat loci (Additional file [1](#MOESM1){ref-type="media"}: Figure S6).

Another kind of difficulty is illustrated by our chimeric human/plasmid reads for *ATXN7* (Fig. [6](#Fig6){ref-type="fig"}c). Here, the reference sequence adjacent to the annotated repeat is similar to the sequence within the repeat. Depending on the exact sequences and alignment parameters, the expanded region of a read may align outside the repeat annotation (Fig. [6](#Fig6){ref-type="fig"}c top) or appear as alignment gaps some distance beyond the repeat (Fig. [6](#Fig6){ref-type="fig"}c bottom). tandem-genotypes handles such cases, up to a point, by examining the alignments out to ad hoc distances beyond the annotated repeat.

Specificity of repeat expansion predictions {#Sec9}
-------------------------------------------

tandem-genotypes can handle custom-made repeat annotation files in BED-like format. We made an annotation file with 31 repeat expansion disease loci, including BAFME, and analyzed these 31 repeats with our BAFME data. No large pathological expansions other than BAFME were predicted (Additional file [1](#MOESM1){ref-type="media"}: Figure S7). We also analyzed these 31 repeats with each of the nanopore and PacBio datasets for NA12878: no obvious pathological expansions were predicted and peaks are around zero in most cases Additional file [1](#MOESM1){ref-type="media"}: Figure S8, S9). These results suggest that our method does not spuriously predict pathological repeat expansions, although there may be some difficulties detecting small disease-causing expansions (e.g., + 2 alanine expansion in *PABPN1* causes disease) due to deviations toward copy number increase in PacBio sequences. We believe this will be solved when sequencing quality improves.

Prioritization of copy number changes: needles in a haystack {#Sec10}
------------------------------------------------------------

Since genome-wide sequencing covers \~ 1 million highly variable tandem repeats, it is necessary to predict which repeat alterations are likely to be important or pathological. Our prioritization method ranked the BAFME repeat expansion 4th out of 0.7 million tandem repeat regions in rmsk.txt (Fig. [7](#Fig7){ref-type="fig"}a). When prioritization was done without any control datasets, it was ranked 13th, so using controls greatly improved prioritization (Fig. [7](#Fig7){ref-type="fig"}c). Repeat expansions in protein-coding regions can cause disease with less than 100 extra copies. So these expansions may be difficult to prioritize. To test this, we combined tandem-genotypes output for the whole genome (NA12878 rel3) with outputs for the plasmid-rel3 chimeric reads with coding-region expansions (*ATN1*, *HTT*, *ATXN2*, *ATXN3*, *CACNA1A*, *ATXN7*, and *AR*). All 7 chimeric expansions were ranked in the top 10 out of 0.7 million repeat regions (Fig. [7](#Fig7){ref-type="fig"}b). Again, controls greatly improved prioritization (Fig. [7](#Fig7){ref-type="fig"}c).Fig. 7**a** Prioritization of predicted repeat copy number changes in a BAFME patient. The BAFME expansion (AAATA: SAMD12 intron) is ranked 4th out of 0.7 million tandem repeats annotated in rmsk.txt. Forward (red) and reverse strand reads (blue) are shown separately. Histograms are raw output of tandem-genotypes-plot. **b** Prioritization of predicted repeat copy number changes in whole genome nanopore reads (NA12878 rel3) plus chimeric human/plasmid reads with pathological triplet-repeat expansions (AR, ATN1, ATXN2, ATXN3, ATXN7, CACNA1A, and HTT). These pathological expansions are prioritized within the top 10 out of 0.7 million tandem repeats in the genome, when compared to three control datasets using tandem-genotypes-join. **c** Comparison to control datasets with tandem-genotypes-join (joined) effectively de-prioritized other repeats, versus only using a single sample (single). *y*-axis: prioritization ranking

Comparing tandem repeat copy number change distribution of MinION, PromethION, and PacBio RSII sequencing data {#Sec11}
--------------------------------------------------------------------------------------------------------------

We next examined the genome-wide repeat copy number changes in the NA12878 human genome sequenced by both PacBio RSII (SRR3197748) and Oxford Nanopore Technology's MinION (rel3). There was marked discordance between MinION and PacBio when the repeat unit size was one or two (Fig. [8](#Fig8){ref-type="fig"}a, Additional file [1](#MOESM1){ref-type="media"}: Figure S10). This is probably because MinION tends to make small deletion errors and PacBio small insertion errors, which are hard to distinguish from copy number changes of these tiny repeat units. Note that a repeat unit size of one means homopolymers (such as AAAAAAAAAA). The triplet-repeat distribution showed a slight difference between MinION and PacBio (Fig. [8](#Fig8){ref-type="fig"}a). However, where the repeat unit is longer than 3, MinION and PacBio had similar distributions of copy number changes (Additional file [1](#MOESM1){ref-type="media"}: Figure S10), so both sequencing platforms work on these tandem repeats. In locus-by-locus comparisons, the repeat copy number changes in nanopore and PacBio reads roughly agree (Additional file [1](#MOESM1){ref-type="media"}: Figures S8 versus S9, Figure S11). Locus-by-locus scatter plots show a clear correlation for repeat unit length \> 1 (Additional file [1](#MOESM1){ref-type="media"}: Figure S12). We also verified that the GGGGCC strand bias, which we observed in the plasmids, is also seen in the rel3 dataset. The distribution of GGGGCC copy number change showed a slight difference between forward and reverse strands (Additional file [1](#MOESM1){ref-type="media"}: Figure S2b).Fig. 8**a** Genome-wide distribution of predicted change in repeat copy number, for nanopore MinION (rel3) and PacBio (SRR3197748) reads from the same human (NA12878). Nanopore tends to have negative and PacBio positive predicted changes, especially for short repeat units. Read number = 10,000 (randomly sampled). Nanopore reads are shown in blue and PacBio in red. **b**--**d** Genome-wide distribution of predicted change in repeat copy number for nanopore MinION (rel3) and PacBio (SRR3197748) reads from the same human (NA12878), and nanopore PromethION (ERR2585112-5) from a different individual (NA19240). **b** Distributions for AG di-nucleotide repeats. **c** Distributions for GAT. **d** Distributions for CTT. CTT shows the most prominent strand bias in nanopore rel3 reads among all types of triplet repeat (all types are in Additional file [1](#MOESM1){ref-type="media"}: Figures S9, S10, S13--S16). PromethION shows less strand bias compared to rel3. *y*-axis: read count, *x*-axis: change in copy number relative to the reference human genome

We examined the distribution of copy number change for all kinds of di- and tri-nucleotide repeat. There are four possible types of di-nucleotide repeat (AG, AT, CG, and AC) and ten kinds of triplet repeat (TAA, GTC, AAC, GAT, CTT, CTG, GTA, CGG, CCT, and CAC). MinION sequences (rel3) showed obvious systematic strand biases for AC, AG, CCT, and CTT (Fig. [8](#Fig8){ref-type="fig"}b, d, Additional file [1](#MOESM1){ref-type="media"}: Figures S13--S15). Note that we do not expect any strand bias for CG and AT because they are palindromic.

The MinION data we tested (rel3) was published in 2017. Nanopore basecallers and chemistries have been improved recently. We tested a recent nanopore MinION dataset analyzed by MinKNOW1.11.5, which uses the Albacore 2.0 basecaller. The strand bias for AC, AG, CCT, and CTT was greatly improved (Additional file [1](#MOESM1){ref-type="media"}: Figure S16). We also tested a recently published human genome dataset sequenced by ONT's new high throughput sequencer PromethION \[[@CR22]\]. We also found that strand biases for AC, AG, CTT, and CCT are greatly improved in PromethION reads (Fig. [8](#Fig8){ref-type="fig"}b, d, Additional file [1](#MOESM1){ref-type="media"}: Figures S17, S18).

Computation time and repeat masking {#Sec12}
-----------------------------------

The slowest computational step was aligning the reads to the genome (lastal). For some datasets, we made it much faster by "masking" repeats (both interspersed and tandem) with WindowMasker. Here, masking means that the repeats (indicated by lowercase letters) are excluded from the similarity-search steps of the alignment algorithm, but are included when making the final alignments: the hope is to find the same alignments faster.

In practice, this masking is often harmless, but sometimes harmful. It did not prevent us from detecting the BAFME expansion, or expansions at ten other disease loci in chimeric human/plasmid reads. On the other hand, it prevented detection of the SCA10 expansions (result not shown). This is because one flank of the SCA10 tandem repeat consists of transposable elements and is almost completely masked. Note this dataset has somewhat short reads (Table [2](#Tab2){ref-type="table"}): the problem would be solved by longer reads that extend beyond the masked region.Table 2Dataset informationNameTypeSequencerIndividual IDAccession numberBasesReadsAverage lengthMedianrel3Human genomeMinIONNA12878\*91,240,120,43314,183,5846432.84617.0SRR3197748Human genomeRSIINA12878SRR3197748176,931,641,32340,820,7044334.43053.0ERR2585112-5Human genomePromethIONNA19240ERR2585112-5185,056,318,46413,134,89014,088.912,551.0BAFMEHuman genomeSequelPrivatePrivate44,835,599,2216,174,3847261.66324.0CAA-15PlasmidMinION--DRR1404973,312,6237264562.84689.5CAA-109PlasmidMinION--DRR1404982,861,0645974792.44962.0GGGGCC-52PlasmidMinION--DRR140499228,298,91150,8844486.74439.0GGGGCC-21PlasmidMinION--DRR140500305,112,10071,0164296.44600.0CAG-6PlasmidMinION--DRR140501170,853,05259,8082856.72935.0CAG-18PlasmidMinION--DRR140502177,739,79531,6445616.95887.0CAG-30PlasmidMinION--DRR140503420,957,360142,0002964.52999.0CAG-30-DraIIIPlasmidMinION--DRR140504104,545,06333,5513116.03026.0CAG-70PlasmidMinION--DRR14050564,609,20118,2323543.73091.5CAG-130PlasmidMinION--DRR14050610,215,54021354784.85002.0CCTG-45PlasmidMinION--DRR1405073,675,4338754200.54605.0SCA10-subjectAPlasmidRSII--SRR208045992,385,18681,6231131.9642.0SCA10-subjectBPlasmidRSII--SRR2081063303,000,76281,7403706.92605.0SCA10-subjectC-PlasmidRSII--SRR2082412157,578,42281,7411927.8893.0SCA10-subjectC-PlasmidRSII--SRR2082428611,539,771163,4763740.91834.0AR-chimerarel3-plasmidMinION----869,8534121,215.913,224.0HTT-chimerarel3-plasmidMinION----518,2354012,955.97462.5CACNA1A-chimerarel3-plasmidMinION----387,9623511,084.69411.0C9orf72-chimerarel3-plasmidMinION----330,2652612,702.59054.5ATXN2-chimerarel3-plasmidMinION----627,8554015,696.48155.0ATXN3-chimerarel3-plasmidMinION----465,4813015,516.014,225.0ATXN7-chimerarel3-plasmidMinION----795,1364816,565.39921.5ATN1-chimerarel3-plasmidMinION----374,363389851.78863.0PPP2R2B-chimerarel3-plasmidMinION----334,4502115,926.28899.0CNBP-chimerarel3-plasmidMinION----361,8613410,643.09349.0\*Downloaded from <https://github.com/nanopore-wgs-consortium/NA12878>

When we do not mask, the total run time for our analysis is competitive with those of RepeatHMM and PacmonSTR (Additional file [1](#MOESM1){ref-type="media"}: Table S2). (Note the last-train run time does not increase much for larger datasets, because it uses a fixed-size sample of the data.) When we do mask, the computation is much faster (Additional file [1](#MOESM1){ref-type="media"}: Table S3), and usually, the results do not change significantly (Additional file [1](#MOESM1){ref-type="media"}: Figure S19). The computing time for whole human genome PacBio and nanopore datasets (with masking) is practical, compared to other aligners such as NGMLR (Additional file [1](#MOESM1){ref-type="media"}: Table S4) (i.e., 37 h for NGMLR and 13 h for LAST with the BAFME data).

Discussion {#Sec13}
==========

We have presented several lines of evidence that we can robustly detect pathological expansions of tandem repeats. We successfully detected them in constructed plasmids, semi-artificial plasmid/human sequences, and real human sequences from PCR-amplified SCA10 locus, PacBio No-Amp sequence of Huntington's disease locus \[[@CR23]\] (Additional file [1](#MOESM1){ref-type="media"}: Figure S20), and PacBio whole genome data from a BAFME patient. We also did *not* detect unexpected (false-positive) large known-pathological expansions in three whole genome datasets: PacBio reads from a BAFME patient, and PacBio and nanopore reads from NA12878. Importantly, we can also rank copy number changes by priority, such that pathological expansions are ranked near the top out of \~ 0.7 million tandem repeats in the genome.

Our method is not specific to tandem expansions, but detects any kind of expansion of a tandem repeat. For example, we detected an expansion due to the insertion of an Alu SINE within a tandem repeat (Fig. [5](#Fig5){ref-type="fig"}a). We also detected an expansion that contained a non-repeat sequence, which turned out to be a deletion in the reference genome (Fig. [5](#Fig5){ref-type="fig"}b). Such non-tandem expansions may impact genomic function and health, so we believe it is useful to detect them too during first-round genome-wide screening.

If a repeat expansion is actually the ancestral state, with the reference genome having a contraction or deletion (e.g., Fig. [5](#Fig5){ref-type="fig"}b), then it is plausible that the expansion is less likely to be pathological. Thus, our prioritization of copy number changes likely benefits from comparing the changes to ape genomes (see the "[Methods](#Sec15){ref-type="sec"}" section). An ancestral reference human genome would be ideal \[[@CR16]\]. A similar idea is to de-prioritize expansions commonly present in healthy humans (Fig. [7](#Fig7){ref-type="fig"}a, b): this will become more powerful as tandem repeat data accumulates.

We have also pointed out some interesting difficulties with analyzing tandem repeat sequences. Some DNA reads do not align with the repetitive region of the reference genome (e.g., Fig. [6](#Fig6){ref-type="fig"}b), and systematic sequencing errors may turn a tandem repeat into a different tandem repeat. The analysis becomes harder when the reference sequence next to an annotated tandem repeat resembles the sequence in the repeat (e.g., Fig. [6](#Fig6){ref-type="fig"}c). Some (inexact) tandem repeats do not have unambiguous boundaries, and different annotations (e.g., RepeatMasker versus Tandem Repeats Finder \[[@CR24]\]) sometimes disagree on the boundaries. In some cases, there may be no unambiguous distinction between the expansion of a tandem repeat and sequence insertion near the repeat. A user may consider adjusting the default treatment of this (see Additional file [1](#MOESM1){ref-type="media"}).

Systematic sequencing errors can have different effects on the two strands of tandemly repeated DNA, causing the predicted copy number changes to have a bimodal distribution (e.g., Fig. [2](#Fig2){ref-type="fig"}i). So it is important to indicate which predictions come from which strands, in order to not misinterpret this as two alleles. We report length and strand biases of several long-read sequencers for every possible type of di- and tri-nucleotide repeat: these biases are prominent for specific repeats (e.g., CTT and CCT in older MinION data), and the worst biases are greatly improved in more recent sequencing systems.

If sequencing accuracy continues to improve, tandem repeat analysis will obviously benefit. The alignment will automatically become faster, due to a lower tolerance of gaps and substitutions. Copy number will be predictable more accurately and with lower coverage.

While this manuscript was in peer-review, tandem-genotypes identified a novel repeat expansion from both nanopore and PacBio whole genome sequencing of multiple families with neuronal intranuclear inclusion disease \[[@CR25]\]. Thus, our method can find the unknown cause of a genetic disease.

Conclusion {#Sec14}
==========

This study demonstrates a practical and robust way to identify changes in tandem repeats that may have biologically impactful consequences. Although there are still limitations due to the developing sequencing technologies and cost to immediately apply this approach in clinical sequencing, we clearly show that there is hope that long-read sequencing is useful to identify overlooked changes in the genome and may give an answer to the large numbers of patients with genetic diseases whose causes and mechanisms have remained unsolved for many years.

Methods {#Sec15}
=======

tandem-genotypes method {#Sec16}
-----------------------

tandem-genotypes has two required inputs: annotations of tandem repeats in a reference genome and alignments of DNA reads to the same genome.

The annotations supply a start and end coordinate for each repeat, and the length *u* of its repeating unit. The repeat length need not be an integer multiple of the unit length. We define two ad hoc distances: "far" *f* = max \[100, *u*\] and "near" *n* = max \[60, *u*\]. (Actually, we truncate *f* at the edge of the sequence: where we speak of *f*, we really mean min \[*f*, distance to the edge of the reference sequence\].)

Last-split finds a division of each DNA read into (one or more) parts and an alignment of each part to the genome. It gives each alignment a "mismap probability," which is high if that part of the read aligns almost equally well to other loci \[[@CR16]\]. We regard one read's alignments as ordered by their 5′ to 3′ positions in the read.

For each DNA read, tandem-genotypes performs these steps:Discard alignments with mismap probability \> 10^−6^.Discard alignments of mostly lowercase sequence. This removes alignments that consist almost entirely of simple sequence (such as atatatatata), which are less reliable. Simple sequence is detected and lowercased by lastdb and lastal, using tantan \[[@CR26]\]. An alignment is discarded if it lacks any segment with score ≥ lastal's score threshold, when "gentle masking" is applied \[[@CR27]\].Join consecutive alignments that are colinear on the same strand of the same chromosome and separated by ≤ 10^6^ bp.Find all alignments that overlap a given repeat.

If there is one such alignment:Require that it extends beyond both sides of the repeat by at least *f*, else give up (i.e., do not use this DNA read for this repeat).Extract all "gaps" from the alignment. Here, one "gap" may have *d* unaligned reference bases and *i* unaligned query bases, flanked by aligned bases. For each gap:◦ If it does not overlap the repeat and *i* ≤ *u*/2: ignore it.◦ If it is wholly ≥ *f* away from the repeat: ignore it.◦ If it is partly ≥ *f* away from the repeat: give up.◦ If it is wholly \> *n* away from the repeat: ignore it.◦ Define *r* to be the number of unaligned reference bases in the gap that are in the repeat.◦ Define the gap's net deletion size: *D* = min(*d*--*i*, *r*).◦ Assume this gap contributes an integer (or zero) copy number change. Find this contribution by rounding *D* to the nearest multiple of *u* (breaking ties by rounding toward zero).

If there is more than one such alignment:Require that they are consecutive in the read and on the same strand.Define the "left" alignment to be the first one if the strand is "+," else the last one. Define the "right" alignment in the opposite way.Require that the left alignment extends leftwards of the repeat and leftwards of the other alignments, by at least *f*. Require that the other alignments do not extend leftwards of the repeat by *f* or more.Likewise for the right alignment.Define the insertion size as the number of query bases, minus the number of reference bases (which could be negative), between the end of the left alignment and the start of the right alignment.Find the nearest multiple of *u* to this insertion size (as above).

Prioritization of copy number changes {#Sec17}
-------------------------------------

The repeats are ranked by priority score. Each repeat has multiple predictions of copy number change, one per DNA read. If the average number of predictions (for repeats with at least 1 prediction) is ≥ 3, ignore the most extreme expansion and contraction per repeat. (Our long-read datasets all have coverage \> 3. This coverage criterion is relevant for using an assembled genome instead of long reads, e.g., chimp versus human.) For each repeat, take the most extreme remaining change and calculate:$$\documentclass[12pt]{minimal}
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(The + 30 provides robustness against dubious repeat annotations, e.g., UCSC RepeatMasker includes triplet repeats of length 6.) This score is multiplied by an ad hoc value per gene annotation, currently 50 for coding, 20 for UTR, 15 for the promoter, 15 for an exon of non-protein-coding RNA, and 5 for intron. This is multiplied by 2 for coding annotations where the repeating unit codes polyglutamine or polyalanine in any reading frame (out of 6). The repeats are ranked by an absolute value of this priority score. The results are robust to small changes of the gene annotation scores (Additional file [1](#MOESM1){ref-type="media"}: Tables S5, S6).

Multi-dataset prioritization {#Sec18}
----------------------------

Suppose we find tandem repeat changes in several individuals with a disease and several individuals without this disease. We wish to prioritize disease-associated changes. For each repeat, calculate *d* = the cubic mean (∛avg. \[*x*^3^\]) of the diseased individuals' priority scores, and *h* = the cubic mean of the non-diseased individuals' priority scores. (We use cubic mean in order to emphasize large values: for example, if just 1 of 3 non-diseased individuals has a large expansion, we still wish to strongly de-prioritize this expansion.) If *d* \< 0, negate *d* and *h*. Finally, the joint priority score is max(*d*--max(*h*, 0), 0).

Public and patient human genome data and alignment to reference genome {#Sec19}
----------------------------------------------------------------------

Human whole genome nanopore (rel3) and PacBio (SRR3197748) sequence data from the same individual (NA12878) were downloaded from (<https://github.com/nanopore-wgs-consortium/NA12878>) and from the SRA database, respectively \[[@CR18]\]. Another 60× coverage human whole genome nanopore dataset from a different individual (NA19240) using PromethION was downloaded from <https://www.ebi.ac.uk/ena/data/view/PRJEB26791>.

Genomic DNA from a human patient with BAFME phenotype was sequenced by PacBio Sequel according to the manufacturer's protocol. Briefly, genomic DNA was sheared by g-TUBE (Covaris, MA, USA), then size selection was done by BluePipin (Sage science, MA, USA) according to the standard method. These datasets were aligned to the human genome (GRCh38) with LAST version 936:WindowMasker -mk_counts -in genome.fa \> genome.wmstatWindowMasker -ustat genome.wmstat -outfmt fasta -in genome.fa \> genome-wm.falastdb -P8 -uNEAR -R11 -c GRCh38 genome-wm.falast-train -P8 GRCh38 reads.fasta \> train.outlastal -P8 -p train.out GRCh38 reads.fasta \| last-split \> alns.maf

Generating tandem repeat containing plasmids {#Sec20}
--------------------------------------------

Plasmids containing various numbers of CAG, GGGGCC, and CAA used for this study were generated as described elsewhere \[[@CR28]--[@CR30]\] and are available upon request (Additional file [1](#MOESM1){ref-type="media"}: Table S7). Sequence data of the plasmids were deposited in (DRA007012, Table [2](#Tab2){ref-type="table"}).

A plasmid with CCTG repeats was generated as follows. Briefly, exon 1 with flanking 225 bp of intron 1 and exon 2 with flanking 1051 bp of intron 1 (including interrupted CCTG~12~ repeats) of the human *CNBP* gene were amplified by PCR using human genome DNA (cat.\# G304A, Promega, WI, USA) and then cloned into pBluescriptII-KS(-) using In-Fusion cloning kit (Clontech Takara, Shiga, Japan). The resulting construct was digested with SalI and XhoI and then ligated with T4 DNA ligase to delete the SalI site in the multi-cloning site of the pBluescriptII-KS(-). A new SalI enzyme site was generated by site-directed mutagenesis after 13 bp of the interrupted CCTG~12~ repeats, to obtain a pBS-CNBP-SalI vector. Oligo DNAs containing CCTG~15~ repeats and flanking sequence, 5′-TCGA (CCTG)~15~C-3′ and 5′-TCGAC (CAGG)~15~--3′, were phosphorylated by T4 polynucleotide kinase, annealed, and then ligated using T4 DNA ligase (Takara, Shiga, Japan). The resulting ligated oligo DNA was digested with SalI and XhoI to remove undesired DNA fragments. Three tandemly ligated oligos were cloned into the SalI site of the pBS-CNBP-SalI vector. This plasmid has CCTG~45~ repeats interrupted by CTCGA in every 15 CCTG repeats, named interrupted CCTG~45~ (iCCTG~45~).

Nanopore sequencing and alignment of tandem repeat containing plasmids {#Sec21}
----------------------------------------------------------------------

These repeat containing plasmids were cut (linearized) with restriction enzymes NheI, EcoRI-HF, BamHI-HF, or DraIII (NEB, MA, USA) (Additional file [1](#MOESM1){ref-type="media"}: Table S7) and then treated with Klenow Fragment DNA Polymerase (Takara, Shiga, Japan) at 37 °C for 30 min. The whole DNA fragments were purified using AmPureXT beads (Agilent Technologies, CA, USA), then subjected to nanopore sequencing. Library preparation was performed using a 1D native barcoding genomic DNA kit (EXP-NBD103 and SQK-LSK108) and then subjected to MinION (Oxford Nanopore Technologies) sequencing using one FLA-MIN106 (R9.4.1) flow cell according to the manufacturer's protocol. Basecalling and fastq conversion were performed with MinKNOW ver1.11.5. De-barcoding was done using EPIME software (Oxford Nanopore Technologies).

Obtained fastq files were transformed to fasta files using seqkit fq2fa option (<http://bioinf.shenwei.me/seqkit>). fasta files were aligned to plasmid references like this:lastdb -P8 -uNEAR -R01 plasmid-ref plasmid.fastalast-train -P8 plasmid-ref reads.fasta \> train.outlastal -P8 -p train.out plasmid-ref reads.fasta \| last-split \> alns.maf

SCA10 data {#Sec22}
----------

SCA10 sequences from three patients with spinocerebellar ataxia 10 (MIM 603516) \[[@CR9]\] were downloaded from SRA (subjectA SRR2080459, subjectB SRR2081063, subjectC-1 SRR2082412, subjectC-2 SRR2082428); then fasta files were generated by this command:fastq-dump \--fasta \--table SEQUENCE \--split-spot \--skip-technical -I \--gzip

Reads were aligned to the human genome (GRCh38) like this:lastdb -P8 -uNEAR -R01 GRCh38 reference.fastalast-train -P8 GRCh38 reads.fasta \> train.outlastal -P8 -p train.out GRCh38 reads.fasta \| last-split \> alns.maf

Comparison to RepeatHMM and PacmonSTR {#Sec23}
-------------------------------------

The SCA10, BAFME, and chimeric reads were analyzed as follows:

PacmonSTR:blasr fasta reference.fa -m 5 \--out blasr.out.m5makeBinnedAnchors.py blasr.out.m5 simpleRepeat.txt 100pacMonStr_V1.py blasr.out.m5 binned_anchors 10 8 current_directory_path

RepeatHMM:repeatHMM.py FASTQinput \--fastq fastq \--Patternfile [hg38.predefined.pa](http://hg38.predefined.pa) \--repeatName gene \--hgfile reference.farepeatHMM.py BAMinput \--Onebamfile bam \--Patternfile [hg38.predefined.pa](http://hg38.predefined.pa) \--repeatName gene \--hgfile reference.fa

For SCA10 subjectA and subjectC-2, after consulting the RepeatHMM authors, we re-ran it with these options added: "-CompRep AlTlT50/C50lClT/C \--SplitAndReAlign 1."

Running tandem-genotypes {#Sec24}
------------------------

The copy number changes of tandem repeats were determined by tandem genotypes v1.1.0 with some different options.

To check all tandem repeats in the human genome in NA12878 data (rel3 and SRR3197748);tandem-genotypes -u 1 -g refFlat.txt rmsk.txt alns.maf

To check disease-related tandem repeats in chimeric reads, BAFME and SCA10 data;tandem-genotypes hg38-disease-tr.txt alns.maf

To check the plasmid sequences;tandem-genotypes plasmid-repeat.bed alns.maf

Tandem repeat (rmsk.txt) and gene (refFlat.txt) annotations were obtained from the UCSC genome database (<http://genome.ucsc.edu/>) \[[@CR31]\]. We made the file hg38-disease-tr.txt, with 31 disease-associated tandem repeats, based on Tang et al. \[[@CR1]\].

Tandem repeat changes in a chimpanzee, relative to the reference human genome, were found like this:tandem-genotypes -g refFlat.txt rmsk.txt hg38-panTro5--1.maf

These alignments (from <https://github.com/mcfrith/last-genome-alignments>) \[[@CR16]\] are of an assembled chimp genome, *not* long reads: our methods work in this case too.

Multi-dataset prioritization was done with commands of this form:tandem-genotypes-join data 1: data 2Data 1: tandem-genotypes output to be prioritizedData 2: tandem-genotypes output to be de-prioritized

For the BAFME patient, two humans and one chimpanzee (NA12878 PacBio SRR3197748, NA19240 PromethION ERR2585112-5, and panTro5) were used for de-prioritizing possibly benign expansions. For rel3 data with coding-region expansions, NA19240 (PromethION ERR2585112-5), the BAFME patient (PacBio), and panTro5 were used for de-prioritization.

Chimeric reads of plasmid-derived repeats and human-derived flanks {#Sec25}
------------------------------------------------------------------

Human nanopore reads covering repeat expansion disease loci were extracted from whole genome sequence data (rel3). The nanopore sequences flanking the repeat were excised using an in-house script. Randomly selected expanded and non-expanded repeat sequences were excised from plasmid nanopore sequences, using maf-cut. Then, these expanded and non-expanded repeats were inserted between the flanks, to generate chimeric reads. The combinations of repeat copy and number of rel3 reads are shown in Table [1](#Tab1){ref-type="table"}, imitating the diploid genome. The chimeric reads were aligned to GRCh38 as mentioned above with WindowMasker \[[@CR32]\].

Dotplot pictures were made with last-dotplot using the following command: last-dotplot \--max-gap2 = 0,inf \--rmsk1 rmsk.txt aln.maf file.png

PCR amplification of inexact repeats in rel3 and PacBio data {#Sec26}
------------------------------------------------------------

Two inexact tandem repeats were tested by PCR and Sanger sequencing. Primers are described in Additional file [1](#MOESM1){ref-type="media"}: Table S8. PCR amplification was done using KAPA HiFi HS DNA polymerase (Kapa Biosystems, Basel, Switzerland). DNA for NA12878 was obtained from the Coriell Institute (<https://coriell.org>). PCR products were cloned into pCR-Blunt vector (Thermo Fisher Scientific, MA, USA) and subjected to Sanger sequencing.

Additional file
===============

 {#Sec27}

Additional file 1:Supplemental methods, results, figures, and tables. (PDF 9545 kb)
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